Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008036 |
ID: | TCMBANKHE008036 |
植物拉丁名: |
|
功能与主治: | See Aconitum carmichaeli./See Aconitum carmichaeli. |
药用植物名: | 多根乌头 |
药用部位: | tuberoid |
TCM_ID_id: | 4957 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN005238 | carnosifloside i | DTXSID50474616; CHEBI:3425; Carnosifloside I; 109985-90-2; C08790; (3S,8S,9R,10R,13R,14S,17R)-17-[(E,1R)-1,5-dimethyl-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-hex-4-enyl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one | C42H68O13 | 781 g/mol | CC(CCC=C(C)COC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)C3CCC4(C3(CC(=O)C5(C4CC=C6C5CCC(C6(C)C)O)C)C)C |
| TCMBANKIN011719 | songorine | Napellonine; Zongorine; 509-24-0; STOCK1N-51040; C08707; MolPort-002-525-082; AKOS030502518; (1R,2R,5S,7R,8R,9R,13R,16S,17R)-11-ETHYL-7,16-DIHYDROXY-13-METHYL-6-METHYLIDENE-11-AZAHEXACYCLO[7.7.2.1?,?.0(1),(1)?.0(2),?.0(1)(3),(1)?]NONADECAN-4-ONE; BG01646908; Songorine; CHEBI:9196 | C22H31NO3 | 357.49 | CCN1CC2(CCC(C34C2CC(C31)C56C4CC(=O)C(C5)C(=C)C6O)O)C |
| TCMBANKIN012446 | Karacolidine | karacolidine | C22H35NO5 | 393.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4(C5C6O)O)OC)O)O)C |
| TCMBANKIN013546 | aconifine | C34H47NO12 | 661.74 | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4(CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)O)OC(=O)C)OC)OC)O)COC | |
| TCMBANKIN025834 | karacoline | Karakoline; 39089-30-0; Karacoline; 20-ethyl-16beta-methoxy-4-methylaconitane-1alpha,8,14alpha-triol; Carmicheline; C08693; STOCK1N-08515; Carmichaeline; CHEBI:6113; Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)- | C22H35NO4 | 377.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN032730 | carmichaeline | Karakoline; 39089-30-0; Karacoline; 20-ethyl-16beta-methoxy-4-methylaconitane-1alpha,8,14alpha-triol; Carmicheline; C08693; STOCK1N-08515; Carmichaeline; CHEBI:6113; Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)- | C22H35NO4 | 377.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN034282 | napelline | C22H33NO3 | 359.5 | CCN1CC2(CCC(C34C2CC(C31)C56C4CC(C(C5)C(=C)C6O)O)O)C | |
| TCMBANKIN058363 | n-phenyl-2-naphthylamine | Fenyl-beta -naftylamin; Phenyl-beta-naphtilamine; 4-12-00-03128 (Beilstein Handbook Reference); I14-13875; AC1L1RHP; NCGC00091111-05; W-108255; N-.beta.-Naphthyl-N-phenylamine; MLS002608023; KEQFTVQCIQJIQW-UHFFFAOYSA-N; N-Phenyl-beta -naphthylamine; Antioxidant PBN; N-2-Naphthylaniline; DTXSID4021131; AC-13068; 52907-17-2; CCRIS 853; N-Phenyl-2-naphthylamine; NCGC00091111-01; HSDB 2888; N-beta-Naphthyl-N-phenylamine; KB-55551; N-Phenyl-beta-naphthylamine; CJ-27101; Fenyl-beta-naftylamin; ACMC-209c4p; P.B.N; A807001; Fenyl-beta-naftylamin [Czech]; Stabilizer AR; RL01609; UNII-456KT854AJ; 2-naphthalenamine,n-phenyl-; KS-00000VGP; AC1Q1IST; AN-23110; Jsp002174; DSSTox_RID_75962; 2-naphthylaniline; Naftam 2; NSC 37151; N-Phenyl-2-naphthylamine, 97%; 135-88-6; 2-(N-Phenylamino)naphthalene; N-beta -naphthyl-N-phenylamine; Phenyl-2-naphthylamine; T6903; NCGC00259440-01; Phenyl-beta-naphthylamine; CHEBI:34877; V0380; N-Fenyl-2-aminonaftalen [Czech]; beta-Naphthylphenylamine; SCHEMBL6435930; Oprea1_737712; Neozone; 2-Naphthylphenylamine; 2-Anilinonaphthalene; N-Phenyl-.beta.-amino-naphthalene; STK367409; 2-Phenylaminonaphthalene; Stabilator AR; PBNA; AJ-29138; BIDD:ER0357; EINECS 205-223-9; SCHEMBL38433; NCGC00091111-02; Antioxidant 116; NCGC00256440-01; ac eto pbn; Neozone D; DB-063104; KSC491Q7L; NSC37151; Noclizer D; AKOS001426472; Nocrac D; Neosone D; 2-NAPHTHYLAMINE, N-PHENYL-; Aceto PBN; CTK3J1875; CJ-06100; 2-Naphthalenamine, N-phenyl-; AK-58488; AI3-00068; Fenyl-.beta.-naftylamin; MCULE-5821072787; NCGC00091111-03; InChI=1/C16H13N/c1-2-8-15(9-3-1)17-16-11-10-13-6-4-5-7-14(13)12-16/h1-12,17; Vulkanox PBN; 456KT854AJ; ST50165453; Nonox DN; phenyl-b-naphthylamine; 2-(n-phenylamino)-naphthalene; N-Phenyl-2-naphthalenamine; 84420-28-0; N-Phenyl-.beta.-naphthylamine; neosone d; [2]naphthyl-phenyl-amine; RTR-004823; DSSTox_CID_1131; CHEMBL1543632; beta -naphthylphenylamine; AC1Q4TNM; N-(2-Naphthyl)-N-phenylamine; NSC-37151; BBL000386; ZINC1669780; C14694; .beta.-Naphthylphenylamine; P0198; Neozon D; A-naphthylamine; Nonox DNStabilizer AR; NCGC00091111-04; Stabilator A.R; WLN: L66J CMR; N-Fenyl-2-aminonaftalen; CAS-135-88-6; LS-19; N-Phenylnaphthalen-2-amine; AgeRite Powder; Nilox PBNA; Tox21_201891; TRA0097315; TR-004823; ST24031437; Nonox D; DSSTox_GSID_21131; NCI-C02915; SMR000112180; phenyl-beta -naphthylamine; AK 1 (stabilizer); N-(2-Naphthyl)aniline; ANW-19991; MFCD00004052; Stabilizator AR; BRN 2211188; MolPort-000-514-795; Antioxygene MC; Tox21_302900; Anilinonaphthalene; N-phenyl-N-; Phenyl-.beta.-naphthylamine;135-88-6; Aceto PBN; WLN: L66J CMR; Phenyl-beta-naphtilamine; Phenyl-2-naphthylamine; 4-12-00-03128 (Beilstein Handbook Reference); Phenyl-beta-naphthylamine; AIDS417346; 2-Naphthalenamine, N-phenyl-; AI3-00068; N-Fenyl-2-aminonaftalen [Czech]; N-phenyl-2-naphthalenamine; InChI=1/C16H13N/c1-2-8-15(9-3-1)17-16-11-10-13-6-4-5-7-14(13)12-16/h1-12,17; Vulkanox PBN; AgeRite Powder; beta-Naphthylphenylamine; Nilox PBNA; Oprea1_737712; Neozone; 2-Anilinonaphthalene; 2-Naphthylphenylamine; N-Phenyl-.beta.-amino-naphthalene; Nonox DN; 2-Phenylaminonaphthalene; Antioxidant PBN; N-2-Naphthylaniline; 52907-17-2; CCRIS 853; 84420-28-0; N-Phenyl-2-naphthylamine; N-Phenyl-.beta.-naphthylamine; NCGC00091111-01; ZINC01669780; HSDB 2888; N-Phenyl-beta-naphthylamine; 178055_ALDRICH; EINECS 205-223-9; NCI-C02915; AIDS-417346; NCGC00091111-02; Fenyl-beta-naftylamin [Czech]; AK 1 (stabilizer); Stabilizer AR; Antioxidant 116; N-(2-Naphthyl)aniline; N-phenylnaphthalen-2-amine; Stabilizator AR; 2-Naphthylamine, N-phenyl-; Neozone D; NSC37151; C14694; AK 1; ST5165453; Noclizer D; 2-naphthyl-phenyl-amine; BRN 2211188; NSC 37151; Naftam 2; Nocrac D; .beta.-Naphthylphenylamine; Anilinonaphthalene; Neozon D; Phenyl-.beta.-naphthylamine;Nonox D | C16H13N | 219.28 g/mol | C1=CC=C(C=C1)NC2=CC3=CC=CC=C3C=C2 |
| TCMBANKIN058603 | sophocarpine | Sophocarpine; ZINC5282946; AIDS-122681; AIDS122681; 145572-44-7 (MONOHYDRATE); (-)-(7aS,13aR,13bR,13cS)-2,3,6,7,7a,8,13,13a,13b,13c-Decahydro-1H,5H,10H-dipyrido[2,1-f:3,2,1-ij][1,6]naphthyridin-10-one; Matridin-15-one, 13,14-didehydro-; Matridin-15-one, 13,14-didehydro- (9CI); (-)-Sophocarpine; 1H,5H,10H-Dipyrido(2,1-f:3',2',1'-ij)(1,6)naphthyridin-10-one, 2,3,6,7,7a,8,13,13a,13b,13c-decahydro-, (7aS,13aR,13bR,13cS)-; BB_NC-1020; 13,14-Didehydromatridin-15-one; (-)-sophocarpine | C15H22N2O | 246.35 g/mol | C1CC2CN3C(CC=CC3=O)C4C2N(C1)CCC4 |
| TCMBANKIN061230 | aconifine | C34H47NO12 | 661.74 g/mol | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4(CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)O)OC(=O)C)OC)OC)O)COC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab